[ 105 ] Nevertheless, the development of nanoplatforms remains highly significant, offering both a technological foundation and a feasible strategic framework for future investigation and intervention in metabolic mechanisms. “Translatability” remains a critical bottleneck in advancing metabolism‐targeted nanomedicine strategies toward clinical application.
← all excerpts
Targeting Multilayered Metabolic Networks in Brain Diseases: Emerging Perspectives on Nanodelivery Strategies.
1
—
—